These two proteins (FGA and APP) might have diagnostic potential in AD from blood, and there are different examination methods available for the utilization of FGA and APP as biomarkers (Irizarry, 2004; Joung Wook et al., 2007; Cortes-Canteli et al., 2012). The gene discussed is APP; the disease is Alzheimer disease.